Hepatitis C virus infection among Greek renal transplant patients

Area of Science:

• Nephrology
• Hepatology
• Transplant Medicine

Background:

• Renal transplant recipients face unique health challenges, including viral infections.
• Hepatitis B virus (HBV) and hepatitis C virus (HCV) are significant concerns in this population.
• Abnormal liver function tests are frequently observed post-transplantation.

Purpose of the Study:

• To determine the prevalence of HCV infection in renal transplant recipients.
• To investigate the relationship between HCV infection and pre- and post-transplant factors.
• To assess the occurrence of liver damage in the context of viral hepatitis and immunosuppression.

Main Methods:

• Prevalence study of HCV infection in renal transplant recipients.
• Correlation analysis of HCV prevalence with duration of hemodialysis and post-transplant time.
• Assessment of HBV infection markers and liver function tests.
• Histopathological evaluation of liver biopsies for viral hepatitis-induced lesions.

Main Results:

• High prevalence of hepatitis C virus (HCV) infection was found in renal transplant recipients.
• HCV prevalence showed a direct correlation with pre-transplant hemodialysis duration.
• A significant inverse relationship was observed between HCV prevalence and post-transplant time.
• Evidence of prior hepatitis B virus (HBV) infection and a high rate of abnormal liver function tests were noted.
• Virus-induced chronic hepatitis lesions were infrequent, potentially due to immunosuppressive therapy.

Conclusions:

• HCV infection is highly prevalent among renal transplant recipients.
• Hemodialysis duration is a key risk factor for HCV infection in this group.
• Immunosuppression may play a protective role against severe liver pathology in virus-infected transplant patients.